SEATTLE (AP) — SEATTLE (AP) — Chinook Therapeutics, Inc. (KDNY) on Monday reported a loss of $66.9 million in its second quarter.
On a per-share basis, the Seattle-based company said it had a loss of 94 cents.
The results did not meet Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 81 cents per share.
The drug developer posted revenue of $1 million in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $466,000.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KDNY at https://www.zacks.com/ap/KDNY
For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights.
, source Associated Press News